We are live on ! Find out more

OXFD

Oxford Immunotec Global PLC Ordinary Shares

OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

80 hedge funds and large institutions have $310M invested in Oxford Immunotec Global PLC Ordinary Shares in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 3 closing their positions.

New

Increased

Maintained

Reduced

Closed

400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 3

45% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 22

13% more capital invested

Capital invested by funds: $274M → $310M (+$36.5M)

10% more funds holding

Funds holding: 73 → 80 (+7)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders

Holders Change

Holders Change %

+9.59%

% of All Funds

1.99%

Holding in Top 10

Holding in Top 10 Change

-1

Holding in Top 10 Change %

-20%

% of All Funds

0.1%

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	BlackRock New York	+$14.3M
2	ECM Endurant Capital Management San Mateo, California	+$7.93M
3	PC Polar Capital London, United Kingdom	+$4.61M
4	Axa Paris, France	+$4.51M
5	RG Redmile Group San Francisco, California	+$4.34M

Top Sellers

Rank	Fund	Capital Flow
1	CV Clarus Ventures Cambridge, Massachusetts	-$10.2M
2	NLVP New Leaf Venture Partners New York	-$3.21M
3	FLAM First Light Asset Management Edina, Minnesota	-$1.79M
4	ACP Acuta Capital Partners Redwood City, California	-$1.21M
5	NIP Nicholas Investment Partners Rancho Santa Fe, California	-$1.02M

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	SIM 26 Spark Investment Management New York	$2.33M	+$1.28M	+89,300	+146%
27	27 Neuberger Berman Group New York	$2.08M	+$1.13M	+79,129	+144%
28	PCM 28 Penn Capital Management Philadelphia, Pennsylvania	$1.83M	+$1.69M	+118,335	New
29	EIM 29 Essex Investment Management Boston, Massachusetts	$1.71M	+$287K	+20,088	+22%
30	USAA 30 United Services Automobile Association San Antonio, Texas	$1.6M	+$1.47M	+103,250	New
31	NA 31 Neuburgh Advisers Los Angeles, California	$1.38M	–	–	–
32	32 Two Sigma Investments New York	$1.38M	+$1.27M	+89,087	New
33	FCM 33 Flinton Capital Management Philadelphia, Pennsylvania	$1.14M	–	–	–
34	34 Russell Investments Group London, United Kingdom	$1.14M	+$1.05M	+73,278	New
35	35 Deutsche Bank Frankfurt Am Main Ge, Germany	$1.13M	+$745K	+52,140	+253%
36	TCIM 36 TIAA CREF Investment Management New York	$1.1M	-$18.6K	-1,301	-2%
37	BC 37 Birchview Capital Burlington, Vermont	$1.04M	–	–	–
38	38 Wells Fargo San Francisco, California	$1.02M	+$531K	+37,163	+129%
39	39 Vanguard Group Malvern, Pennsylvania	$1.01M	+$17.7K	+1,238	+2%
40	KCM 40 Kornitzer Capital Management Shawnee Mission, Kansas	$934K	-$231K	-16,200	-21%
41	41 D.E. Shaw & Co New York	$897K	+$313K	+21,902	+61%
42	TAM 42 Tyers Asset Management Austin, Texas	$895K	–	–	–
43	43 Bank of New York Mellon New York	$854K	-$217K	-15,175	-22%
44	44 Millennium Management New York	$826K	+$761K	+53,308	New
45	45 Geode Capital Management Boston, Massachusetts	$760K	+$83.7K	+5,858	+14%
46	TA 46 Teachers Advisors New York	$716K	+$89.5K	+6,268	+16%
47	47 KeyBank National Association Cleveland, Ohio	$712K	–	–	–
48	48 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$678K	-$27.1K	-1,900	-4%
49	GHCM 49 Glen Harbor Capital Management San Diego, California	$651K	–	–	–
50	50 Charles Schwab San Francisco, California	$628K	–	–	–

OXFD Hedge Fund Activity: Q1 2017 in Review

80 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q1 2017, worth a combined $310M — up 13% from $274M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new OXFD positions and 3 closed out — a net gain of 12 holders — while 32 added to existing stakes and 22 trimmed.

The largest buyer was BlackRock, adding an estimated $14.3M. The largest seller was Clarus Ventures, cutting an estimated $10.2M.

80 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q1 2017, up from 73 in Q4 2016.
Funds reported $310M of Oxford Immunotec Global PLC Ordinary Shares stock for Q1 2017, up 13% quarter-over-quarter.
15 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q1 2017 and 3 closed out, a net change of +12 holders.
The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q1 2017 was BlackRock, an estimated $14.3M added.
The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q1 2017 was Clarus Ventures, an estimated $10.2M sold.

Based on aggregated 13F filings for Q1 2017.

Oxford Immunotec Global PLC Ordinary Shares OXFD